APP vs REGN · P/E 61, rev $5.48B vs P/E 14, rev $14.34B
Applovin Corp (APP) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Applovin Corp (APP) is a advertising agencies company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported APP revenue for 2025-12-31 was $5.48B. Net income was $3.33B. Revenue was up 16.4% from 2024-12-31 to 2025-12-31. APP currently screens at market cap $113.70B and trailing P/E 61.0.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
APP currently screens at market cap $113.70B and trailing P/E 61.0. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the APP and REGN stock pages for the full models.
Not investment advice.